Line 2,394: |
Line 2,394: |
| |}<br /> | | |}<br /> |
| | | |
− | ==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)== | + | ==WHO Central Nervous System Tumours (5th ed.) Content== |
− | {| class="wikitable sortable" | + | {| class="wikitable" |
− | !'''Gene''' | + | |- |
− | !'''Author''' | + | !'''Disease'''!!'''Page Type'''!!'''Author''' |
| !'''Date Assigned to Author''' | | !'''Date Assigned to Author''' |
| !'''Target Completion Date''' | | !'''Target Completion Date''' |
| !'''Author Content (Pending or Complete)''' | | !'''Author Content (Pending or Complete)''' |
− | !'''Date Completed by Author''' | + | !'''Date Completed by Author'''!!'''Associate Editor''' |
− | !'''Associate Editor''' | |
| !'''Date of Last Editor Review''' | | !'''Date of Last Editor Review''' |
| !'''Notes''' | | !'''Notes''' |
− | |- | + | |- |Astrocytoma, IDH-mutant||Disease|| |
− | |BCR | + | | |
− | |Brian Davis | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |8/10/18
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |ABL1 | + | |Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| |
− | |Brian Davis | + | | |
| + | | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |4/16/19
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |RUNX1 | + | |Glioblastoma, IDH-wildtype||Disease|| |
− | |Brian Davis | + | | |
| + | | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |6/9/19
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |RUNX1T1 | + | |Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| |
− | |Brian Davis | + | | |
| + | | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |5/23/19
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |MYH11 | + | |Angiocentric glioma||Disease|| |
− | |Brian Davis | + | | |
| + | | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |8/6/18
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |FLT3 | + | |Polymorphous low-grade neuroepithelial tumour of the young||Disease|| |
− | |Kay Weng Choy | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,466: |
Line 2,458: |
| | | | | |
| |- | | |- |
− | |NPM1 | + | |Diffuse low-grade glioma, MAPK pathway-altered||Disease|| |
− | |Kay Weng Choy | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,476: |
Line 2,467: |
| | | | | |
| |- | | |- |
− | |TP53 | + | |Diffuse midline glioma, H3 K27-altered||Disease|| |
− | |Kay Weng Choy | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,486: |
Line 2,476: |
| | | | | |
| |- | | |- |
− | |DNMT3A | + | |Diffuse hemispheric glioma, H3 G34-mutant||Disease|| |
− | |Kay Weng Choy | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,496: |
Line 2,485: |
| | | | | |
| |- | | |- |
− | |CEBPA | + | |Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| |
− | |Gordana | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,506: |
Line 2,494: |
| | | | | |
| |- | | |- |
− | |IDH1 | + | |Infant-type hemispheric glioma||Disease|| |
− | |Paul De Fazio | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,516: |
Line 2,503: |
| | | | | |
| |- | | |- |
− | |IDH2 | + | |Pilocytic astrocytoma||Disease|| |
− | |Paul De Fazio | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,526: |
Line 2,512: |
| | | | | |
| |- | | |- |
− | |PML | + | |High-grade astrocytoma with piloid features||Disease|| |
− | |Brian Davis | + | | |
| + | | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |12/5/18
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |RARA | + | |Pleomorphic xanthoastrocytoma||Disease|| |
− | |Brian Davis | + | | |
| + | | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |8/3/18
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |ETV6 | + | |Subependymal giant cell astrocytoma||Disease|| |
− | |Brian Davis | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |6/9/19
| |
| | | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |KIT
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Complete | + | |- |
− | |10/1/18 | + | |Chordoid glioma||Disease|| |
| | | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |CBFB
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Complete
| |
− | |8/2/18
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |GATA2 | + | |Astroblastoma, MN1-altered||Disease|| |
− | |Kay Weng Choy | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,586: |
Line 2,557: |
| | | | | |
| |- | | |- |
− | |PTEN | + | |Ganglioglioma||Disease|| |
− | |Beth Pitel | + | | |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,596: |
Line 2,566: |
| | | | | |
| |- | | |- |
− | |MLTT3 | + | |Gangliocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,604: |
Line 2,574: |
| | | | | |
| | | | | |
| + | |- |
| + | |Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| |
| | | | | |
− | |-
| |
− | |MECOM
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,616: |
Line 2,584: |
| | | | | |
| |- | | |- |
− | |FGFR1(FLT2) | + | |Dysembryoplastic neuroepithelial tumour||Disease|| |
− | |Brian Davis | + | | |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,626: |
Line 2,593: |
| | | | | |
| |- | | |- |
− | |KMT2A | + | |Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| |
| | | | | |
| | | | | |
Line 2,634: |
Line 2,601: |
| | | | | |
| | | | | |
| + | |- |
| + | |Papillary glioneuronal tumour||Disease|| |
| | | | | |
− | |-
| |
− | |DEK
| |
− | |Wahab A. Khan
| |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,646: |
Line 2,611: |
| | | | | |
| |- | | |- |
− | |NUP214 | + | |Rosette-forming glioneuronal tumour||Disease|| |
− | |Wahab A. Khan | + | | |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,656: |
Line 2,620: |
| | | | | |
| |- | | |- |
− | |RBM15 | + | |Myxoid glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,664: |
Line 2,628: |
| | | | | |
| | | | | |
| + | |- |
| + | |Diffuse leptomeningeal glioneuronal tumour||Disease|| |
| | | | | |
− | |-
| |
− | |MKL1
| |
| | | | | |
| | | | | |
Line 2,673: |
Line 2,637: |
| | | | | |
| | | | | |
| + | |- |
| + | |Multinodular and vacuolating neuronal tumour||Disease|| |
| | | | | |
| | | | | |
− | |-
| |
− | |DDX41
| |
− | |Ying Zou
| |
− | |8/7/20
| |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,686: |
Line 2,647: |
| | | | | |
| |- | | |- |
− | |ANKRD26 | + | |Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,696: |
Line 2,656: |
| | | | | |
| |- | | |- |
− | |CUX1 | + | |Central neurocytoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,706: |
Line 2,665: |
| | | | | |
| |- | | |- |
− | |TET2 | + | |Extraventricular neurocytoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,716: |
Line 2,674: |
| | | | | |
| |- | | |- |
− | |EZH2 | + | |Cerebellar liponeurocytoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,726: |
Line 2,683: |
| | | | | |
| |- | | |- |
− | |FOXP1 | + | |Supratentorial ependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,736: |
Line 2,692: |
| | | | | |
| |- | | |- |
− | |MYC | + | |Supratentorial ependymoma, ZFTA fusion-positive||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,746: |
Line 2,701: |
| | | | | |
| |- | | |- |
− | |JAK2 | + | |Supratentorial ependymoma, YAP1 fusion-positive||Disease|| |
| | | | | |
| | | | | |
Line 2,754: |
Line 2,709: |
| | | | | |
| | | | | |
| + | |- |
| + | |Posterior fossa ependymoma||Disease|| |
| | | | | |
− | |-
| |
− | |WT1
| |
− | |DONE
| |
| | | | | |
| | | | | |
− | |DONE
| |
| | | | | |
| | | | | |
Line 2,766: |
Line 2,719: |
| | | | | |
| |- | | |- |
− | |CBL | + | |Posterior fossa group A (PFA) ependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,776: |
Line 2,728: |
| | | | | |
| |- | | |- |
− | |NF1 | + | |Posterior fossa group B (PFB) ependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,786: |
Line 2,737: |
| | | | | |
| |- | | |- |
− | |SUZ12 | + | |Spinal ependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,796: |
Line 2,746: |
| | | | | |
| |- | | |- |
− | |ERG | + | |Spinal ependymoma, MYCN-amplified||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,806: |
Line 2,755: |
| | | | | |
| |- | | |- |
− | |EST2 | + | |Myxopapillary ependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,816: |
Line 2,764: |
| | | | | |
| |- | | |- |
− | |RPS14 | + | |Subependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,826: |
Line 2,773: |
| | | | | |
| |- | | |- |
− | |RB1 | + | |Choroid plexus papilloma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,836: |
Line 2,782: |
| | | | | |
| |- | | |- |
− | |MPL | + | |Atypical choroid plexus papilloma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,846: |
Line 2,791: |
| | | | | |
| |- | | |- |
− | |CHGA | + | |Choroid plexus carcinoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,856: |
Line 2,800: |
| | | | | |
| |- | | |- |
− | |CDH1 | + | |Medulloblastoma, WNT-activated||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,866: |
Line 2,809: |
| | | | | |
| |- | | |- |
− | |SRSF2 | + | |Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,876: |
Line 2,818: |
| | | | | |
| |- | | |- |
− | |DNMT1 | + | |Medulloblastoma, SHH-activated and TP53-mutant||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,886: |
Line 2,827: |
| | | | | |
| |- | | |- |
− | |PRDX2 | + | |Medulloblastoma, non-WNT/non-SHH||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,896: |
Line 2,836: |
| | | | | |
| |- | | |- |
− | |ASXL1 | + | |Medulloblastoma, histologically defined||Disease|| |
− | |DONE | + | | |
| | | | | |
| | | | | |
− | |DONE
| |
| | | | | |
| | | | | |
Line 2,906: |
Line 2,845: |
| | | | | |
| |- | | |- |
− | |MN1 | + | |Atypical teratoid/rhabdoid tumour||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,916: |
Line 2,854: |
| | | | | |
| |- | | |- |
− | |SF3A1 | + | |Cribriform neuroepithelial tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,924: |
Line 2,862: |
| | | | | |
| | | | | |
| + | |- |
| + | |Embryonal tumour with multilayered rosettes||Disease|| |
| | | | | |
− | |-
| |
− | |EP300
| |
| | | | | |
| | | | | |
Line 2,933: |
Line 2,871: |
| | | | | |
| | | | | |
| + | |- |
| + | |CNS neuroblastoma, FOXR2-activated||Disease|| |
| | | | | |
| | | | | |
− | |-
| |
− | |JARID2
| |
| | | | | |
| | | | | |
Line 2,942: |
Line 2,880: |
| | | | | |
| | | | | |
| + | |- |
| + | |CNS tumour with BCOR internal tandem duplication||Disease|| |
| | | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |BRCA1
| |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |CNS embryonal tumour NEC/NOS||Disease|| |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |BRCA2
| |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |Pineocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,965: |
Line 2,905: |
| | | | | |
| | | | | |
− | |-
| |
| | | | | |
| | | | | |
| + | |- |
| + | |Pineal parenchymal tumour of intermediate differentiation||Disease|| |
| | | | | |
| | | | | |
Line 2,976: |
Line 2,917: |
| | | | | |
| |- | | |- |
| + | |Pineoblastoma||Disease|| |
| + | | |
| | | | | |
| | | | | |
Line 2,982: |
Line 2,925: |
| | | | | |
| | | | | |
− | | | + | |- |
− | | | + | |Papillary tumour of the pineal region||Disease|| |
− | |
| |
− | |}
| |
− | | |
− | ==WHO Central Nervous System Tumours (5th ed.) Content==
| |
− | {| class="wikitable"
| |
− | |-
| |
− | !'''Disease'''!!'''Page Type'''!!'''Author'''
| |
− | !'''Date Assigned to Author'''
| |
− | !'''Target Completion Date'''
| |
− | !'''Author Content (Pending or Complete)'''
| |
− | !'''Date Completed by Author'''!!'''Associate Editor'''
| |
− | !'''Date of Last Editor Review'''
| |
− | !'''Notes'''
| |
− | |- |Astrocytoma, IDH-mutant||Disease||
| |
| | | | | |
| | | | | |
Line 3,006: |
Line 2,935: |
| | | | | |
| |- | | |- |
− | |Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| | + | |Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,015: |
Line 2,944: |
| | | | | |
| |- | | |- |
− | |Glioblastoma, IDH-wildtype||Disease|| | + | |Schwannoma||Disease|| |
| | | | | |
| | | | | |
Line 3,024: |
Line 2,953: |
| | | | | |
| |- | | |- |
− | |Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| | + | |Neurofibroma||Disease|| |
| | | | | |
| | | | | |
Line 3,033: |
Line 2,962: |
| | | | | |
| |- | | |- |
− | |Angiocentric glioma||Disease|| | + | |Perineurioma||Disease|| |
| | | | | |
| | | | | |
Line 3,042: |
Line 2,971: |
| | | | | |
| |- | | |- |
− | |Polymorphous low-grade neuroepithelial tumour of the young||Disease|| | + | |Hybrid nerve sheath tumours||Disease|| |
| | | | | |
| | | | | |
Line 3,051: |
Line 2,980: |
| | | | | |
| |- | | |- |
− | |Diffuse low-grade glioma, MAPK pathway-altered||Disease|| | + | |Malignant melanotic nerve sheath tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,060: |
Line 2,989: |
| | | | | |
| |- | | |- |
− | |Diffuse midline glioma, H3 K27-altered||Disease|| | + | |Malignant peripheral nerve sheath tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,069: |
Line 2,998: |
| | | | | |
| |- | | |- |
− | |Diffuse hemispheric glioma, H3 G34-mutant||Disease|| | + | |Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| |
| | | | | |
| | | | | |
Line 3,078: |
Line 3,007: |
| | | | | |
| |- | | |- |
− | |Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| | + | |Meningioma||Disease|| |
| | | | | |
| | | | | |
Line 3,087: |
Line 3,016: |
| | | | | |
| |- | | |- |
− | |Infant-type hemispheric glioma||Disease|| | + | |Solitary fibrous tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,096: |
Line 3,025: |
| | | | | |
| |- | | |- |
− | |Pilocytic astrocytoma||Disease|| | + | |Haemangiomas and vascular malformations||Disease|| |
| | | | | |
| | | | | |
Line 3,105: |
Line 3,034: |
| | | | | |
| |- | | |- |
− | |High-grade astrocytoma with piloid features||Disease|| | + | |Haemangioblastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,114: |
Line 3,043: |
| | | | | |
| |- | | |- |
− | |Pleomorphic xanthoastrocytoma||Disease|| | + | |Rhabdomyosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,123: |
Line 3,052: |
| | | | | |
| |- | | |- |
− | |Subependymal giant cell astrocytoma||Disease|| | + | |Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| |
| | | | | |
| | | | | |
Line 3,132: |
Line 3,061: |
| | | | | |
| |- | | |- |
− | |Chordoid glioma||Disease|| | + | |CIC-rearranged sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,141: |
Line 3,070: |
| | | | | |
| |- | | |- |
− | |Astroblastoma, MN1-altered||Disease|| | + | |Primary intracranial sarcoma, DICER1-mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,150: |
Line 3,079: |
| | | | | |
| |- | | |- |
− | |Ganglioglioma||Disease|| | + | |Ewing sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,159: |
Line 3,088: |
| | | | | |
| |- | | |- |
− | |Gangliocytoma||Disease|| | + | |Mesenchymal chondrosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,168: |
Line 3,097: |
| | | | | |
| |- | | |- |
− | |Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| | + | |Chondrosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,177: |
Line 3,106: |
| | | | | |
| |- | | |- |
− | |Dysembryoplastic neuroepithelial tumour||Disease|| | + | |Chordoma||Disease|| |
| | | | | |
| | | | | |
Line 3,186: |
Line 3,115: |
| | | | | |
| |- | | |- |
− | |Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| | + | |Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,195: |
Line 3,124: |
| | | | | |
| |- | | |- |
− | |Papillary glioneuronal tumour||Disease|| | + | |Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| |
| | | | | |
| | | | | |
Line 3,204: |
Line 3,133: |
| | | | | |
| |- | | |- |
− | |Rosette-forming glioneuronal tumour||Disease|| | + | |Primary diffuse large B-cell lymphoma of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,213: |
Line 3,142: |
| | | | | |
| |- | | |- |
− | |Myxoid glioneuronal tumour||Disease|| | + | |Immunodeficiency-associated CNS lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 3,222: |
Line 3,151: |
| | | | | |
| |- | | |- |
− | |Diffuse leptomeningeal glioneuronal tumour||Disease|| | + | |Lymphomatoid granulomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,231: |
Line 3,160: |
| | | | | |
| |- | | |- |
− | |Multinodular and vacuolating neuronal tumour||Disease|| | + | |Intravascular large B-cell lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 3,240: |
Line 3,169: |
| | | | | |
| |- | | |- |
− | |Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| | + | |MALT lymphoma of the dura||Disease|| |
| | | | | |
| | | | | |
Line 3,249: |
Line 3,178: |
| | | | | |
| |- | | |- |
− | |Central neurocytoma||Disease|| | + | |Other low-grade B-cell lymphomas of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,258: |
Line 3,187: |
| | | | | |
| |- | | |- |
− | |Extraventricular neurocytoma||Disease|| | + | |Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| |
| | | | | |
| | | | | |
Line 3,267: |
Line 3,196: |
| | | | | |
| |- | | |- |
− | |Cerebellar liponeurocytoma||Disease|| | + | |T-cell and NK/T-cell lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 3,276: |
Line 3,205: |
| | | | | |
| |- | | |- |
− | |Supratentorial ependymoma||Disease|| | + | |Erdheim-Chester disease||Disease|| |
| | | | | |
| | | | | |
Line 3,285: |
Line 3,214: |
| | | | | |
| |- | | |- |
− | |Supratentorial ependymoma, ZFTA fusion-positive||Disease|| | + | |Rosai-Dorfman disease||Disease|| |
| | | | | |
| | | | | |
Line 3,294: |
Line 3,223: |
| | | | | |
| |- | | |- |
− | |Supratentorial ependymoma, YAP1 fusion-positive||Disease|| | + | |Juvenile xanthogranuloma||Disease|| |
| | | | | |
| | | | | |
Line 3,303: |
Line 3,232: |
| | | | | |
| |- | | |- |
− | |Posterior fossa ependymoma||Disease|| | + | |Langerhans cell histiocytosis||Disease|| |
| | | | | |
| | | | | |
Line 3,312: |
Line 3,241: |
| | | | | |
| |- | | |- |
− | |Posterior fossa group A (PFA) ependymoma||Disease|| | + | |Histiocytic sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,321: |
Line 3,250: |
| | | | | |
| |- | | |- |
− | |Posterior fossa group B (PFB) ependymoma||Disease|| | + | |Germ cell tumours of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,330: |
Line 3,259: |
| | | | | |
| |- | | |- |
− | |Spinal ependymoma||Disease|| | + | |Adamantinomatous craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,339: |
Line 3,268: |
| | | | | |
| |- | | |- |
− | |Spinal ependymoma, MYCN-amplified||Disease|| | + | |Papillary craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,348: |
Line 3,277: |
| | | | | |
| |- | | |- |
− | |Myxopapillary ependymoma||Disease|| | + | |Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,357: |
Line 3,286: |
| | | | | |
| |- | | |- |
− | |Subependymoma||Disease|| | + | |Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,366: |
Line 3,295: |
| | | | | |
| |- | | |- |
− | |Choroid plexus papilloma||Disease|| | + | |Pituitary blastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,375: |
Line 3,304: |
| | | | | |
| |- | | |- |
− | |Atypical choroid plexus papilloma||Disease|| | + | |Metastases to the brain and spinal cord parenchyma||Disease|| |
| | | | | |
| | | | | |
Line 3,384: |
Line 3,313: |
| | | | | |
| |- | | |- |
− | |Choroid plexus carcinoma||Disease|| | + | |Metastases to the meninges||Disease|| |
| | | | | |
| | | | | |
Line 3,393: |
Line 3,322: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, WNT-activated||Disease|| | + | |Neurofibromatosis type 1||Disease|| |
| | | | | |
| | | | | |
Line 3,402: |
Line 3,331: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| | + | |Neurofibromatosis type 2||Disease|| |
| | | | | |
| | | | | |
Line 3,411: |
Line 3,340: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, SHH-activated and TP53-mutant||Disease|| | + | |Schwannomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,420: |
Line 3,349: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, non-WNT/non-SHH||Disease|| | + | |Von Hippel-Lindau syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,429: |
Line 3,358: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, histologically defined||Disease|| | + | |Tuberous sclerosis||Disease|| |
| | | | | |
| | | | | |
Line 3,438: |
Line 3,367: |
| | | | | |
| |- | | |- |
− | |Atypical teratoid/rhabdoid tumour||Disease|| | + | |Li-Fraumeni syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,447: |
Line 3,376: |
| | | | | |
| |- | | |- |
− | |Cribriform neuroepithelial tumour||Disease|| | + | |Cowden syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,456: |
Line 3,385: |
| | | | | |
| |- | | |- |
− | |Embryonal tumour with multilayered rosettes||Disease|| | + | |Constitutional mismatch repair deficiency syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,465: |
Line 3,394: |
| | | | | |
| |- | | |- |
− | |CNS neuroblastoma, FOXR2-activated||Disease|| | + | |Familial adenomatous polyposis 1||Disease|| |
| | | | | |
| | | | | |
Line 3,474: |
Line 3,403: |
| | | | | |
| |- | | |- |
− | |CNS tumour with BCOR internal tandem duplication||Disease|| | + | |Naevoid basal cell carcinoma syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,483: |
Line 3,412: |
| | | | | |
| |- | | |- |
− | |CNS embryonal tumour NEC/NOS||Disease|| | + | |Rhabdoid tumour predisposition syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,492: |
Line 3,421: |
| | | | | |
| |- | | |- |
− | |Pineocytoma||Disease|| | + | |Carney complex||Disease|| |
| | | | | |
| | | | | |
Line 3,501: |
Line 3,430: |
| | | | | |
| |- | | |- |
− | |Pineal parenchymal tumour of intermediate differentiation||Disease|| | + | |DICER1 syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,510: |
Line 3,439: |
| | | | | |
| |- | | |- |
− | |Pineoblastoma||Disease|| | + | |Familial paraganglioma syndromes||Disease|| |
| | | | | |
| | | | | |
Line 3,519: |
Line 3,448: |
| | | | | |
| |- | | |- |
− | |Papillary tumour of the pineal region||Disease|| | + | |Melanoma-astrocytoma syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,528: |
Line 3,457: |
| | | | | |
| |- | | |- |
− | |Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| | + | |Familial retinoblastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,537: |
Line 3,466: |
| | | | | |
| |- | | |- |
− | |Schwannoma||Disease|| | + | |BAP1 tumour predisposition syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,546: |
Line 3,475: |
| | | | | |
| |- | | |- |
− | |Neurofibroma||Disease|| | + | |Fanconi anaemia||Disease|| |
| | | | | |
| | | | | |
Line 3,555: |
Line 3,484: |
| | | | | |
| |- | | |- |
− | |Perineurioma||Disease|| | + | |ELP1-medulloblastoma syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,564: |
Line 3,493: |
| | | | | |
| |- | | |- |
− | |Hybrid nerve sheath tumours||Disease|| | + | |} |
| + | |
| + | ==WHO Breast tumours (5th ed.) Content== |
| + | {| class="wikitable" |
| + | |- |
| + | !'''Disease'''!!'''Page Type'''!!'''Author''' |
| + | !'''Date Assigned to Author''' |
| + | !'''Target Completion Date''' |
| + | !'''Author Content (Pending or Complete)''' |
| + | !'''Date Completed by Author'''!!'''Associate Editor''' |
| + | !'''Date of Last Editor Review''' |
| + | !'''Notes''' |
| + | |- |Usual ductal hyperplasia||Disease|| |
| | | | | |
| | | | | |
Line 3,573: |
Line 3,514: |
| | | | | |
| |- | | |- |
− | |Malignant melanotic nerve sheath tumour||Disease|| | + | |Columnar cell lesions, including flat epithelial atypia||Disease|| |
| | | | | |
| | | | | |
Line 3,582: |
Line 3,523: |
| | | | | |
| |- | | |- |
− | |Malignant peripheral nerve sheath tumour||Disease|| | + | |Atypical ductal hyperplasia||Disease|| |
| | | | | |
| | | | | |
Line 3,591: |
Line 3,532: |
| | | | | |
| |- | | |- |
− | |Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| | + | |Sclerosing adenosis||Disease|| |
| | | | | |
| | | | | |
Line 3,600: |
Line 3,541: |
| | | | | |
| |- | | |- |
− | |Meningioma||Disease|| | + | |Apocrine adenosis and adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,609: |
Line 3,550: |
| | | | | |
| |- | | |- |
− | |Solitary fibrous tumour||Disease|| | + | |Microglandular adenosis||Disease|| |
| | | | | |
| | | | | |
Line 3,618: |
Line 3,559: |
| | | | | |
| |- | | |- |
− | |Haemangiomas and vascular malformations||Disease|| | + | |Radial scar / complex sclerosing lesion||Disease|| |
| | | | | |
| | | | | |
Line 3,627: |
Line 3,568: |
| | | | | |
| |- | | |- |
− | |Haemangioblastoma||Disease|| | + | |Tubular adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,636: |
Line 3,577: |
| | | | | |
| |- | | |- |
− | |Rhabdomyosarcoma||Disease|| | + | |Lactating adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,645: |
Line 3,586: |
| | | | | |
| |- | | |- |
− | |Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| | + | |Ductal adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,654: |
Line 3,595: |
| | | | | |
| |- | | |- |
− | |CIC-rearranged sarcoma||Disease|| | + | |Pleomorphic adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,663: |
Line 3,604: |
| | | | | |
| |- | | |- |
− | |Primary intracranial sarcoma, DICER1-mutant||Disease|| | + | |Adenomyoepithelioma||Disease|| |
| | | | | |
| | | | | |
Line 3,672: |
Line 3,613: |
| | | | | |
| |- | | |- |
− | |Ewing sarcoma||Disease|| | + | |Malignant adenomyoepithelioma||Disease|| |
| | | | | |
| | | | | |
Line 3,681: |
Line 3,622: |
| | | | | |
| |- | | |- |
− | |Mesenchymal chondrosarcoma||Disease|| | + | |Intraductal papilloma||Disease|| |
| | | | | |
| | | | | |
Line 3,690: |
Line 3,631: |
| | | | | |
| |- | | |- |
− | |Chondrosarcoma||Disease|| | + | |Papillary ductal carcinoma in situ||Disease|| |
| | | | | |
| | | | | |
Line 3,699: |
Line 3,640: |
| | | | | |
| |- | | |- |
− | |Chordoma||Disease|| | + | |Encapsulated papillary carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,708: |
Line 3,649: |
| | | | | |
| |- | | |- |
− | |Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| | + | |Solid papillary carcinoma (in situ and invasive)||Disease|| |
| | | | | |
| | | | | |
Line 3,717: |
Line 3,658: |
| | | | | |
| |- | | |- |
− | |Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| | + | |Invasive papillary carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,726: |
Line 3,667: |
| | | | | |
| |- | | |- |
− | |Primary diffuse large B-cell lymphoma of the CNS||Disease|| | + | |Atypical lobular hyperplasia||Disease|| |
| | | | | |
| | | | | |
Line 3,735: |
Line 3,676: |
| | | | | |
| |- | | |- |
− | |Immunodeficiency-associated CNS lymphomas||Disease|| | + | |Lobular carcinoma in situ||Disease|| |
| | | | | |
| | | | | |
Line 3,744: |
Line 3,685: |
| | | | | |
| |- | | |- |
− | |Lymphomatoid granulomatosis||Disease|| | + | |Ductal carcinoma in situ||Disease|| |
| | | | | |
| | | | | |
Line 3,753: |
Line 3,694: |
| | | | | |
| |- | | |- |
− | |Intravascular large B-cell lymphoma||Disease|| | + | |Invasive breast carcinoma: General overview||Disease|| |
| | | | | |
| | | | | |
Line 3,762: |
Line 3,703: |
| | | | | |
| |- | | |- |
− | |MALT lymphoma of the dura||Disease|| | + | |Invasive breast carcinoma of no special type||Disease|| |
| | | | | |
| | | | | |
Line 3,771: |
Line 3,712: |
| | | | | |
| |- | | |- |
− | |Other low-grade B-cell lymphomas of the CNS||Disease|| | + | |Microinvasive carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,780: |
Line 3,721: |
| | | | | |
| |- | | |- |
− | |Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| | + | |Invasive lobular carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,789: |
Line 3,730: |
| | | | | |
| |- | | |- |
− | |T-cell and NK/T-cell lymphomas||Disease|| | + | |Tubular carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,798: |
Line 3,739: |
| | | | | |
| |- | | |- |
− | |Erdheim-Chester disease||Disease|| | + | |Cribriform carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,807: |
Line 3,748: |
| | | | | |
| |- | | |- |
− | |Rosai-Dorfman disease||Disease|| | + | |Mucinous carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,816: |
Line 3,757: |
| | | | | |
| |- | | |- |
− | |Juvenile xanthogranuloma||Disease|| | + | |Mucinous cystadenocarcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,825: |
Line 3,766: |
| | | | | |
| |- | | |- |
− | |Langerhans cell histiocytosis||Disease|| | + | |Invasive micropapillary carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,834: |
Line 3,775: |
| | | | | |
| |- | | |- |
− | |Histiocytic sarcoma||Disease|| | + | |Carcinoma with apocrine differentiation||Disease|| |
| | | | | |
| | | | | |
Line 3,843: |
Line 3,784: |
| | | | | |
| |- | | |- |
− | |Germ cell tumours of the CNS||Disease|| | + | |Metaplastic carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,852: |
Line 3,793: |
| | | | | |
| |- | | |- |
− | |Adamantinomatous craniopharyngioma||Disease|| | + | |Acinic cell carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,861: |
Line 3,802: |
| | | | | |
| |- | | |- |
− | |Papillary craniopharyngioma||Disease|| | + | |Adenoid cystic carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,870: |
Line 3,811: |
| | | | | |
| |- | | |- |
− | |Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| | + | |Secretory carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,879: |
Line 3,820: |
| | | | | |
| |- | | |- |
− | |Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| | + | |Mucoepidermoid carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,888: |
Line 3,829: |
| | | | | |
| |- | | |- |
− | |Pituitary blastoma||Disease|| | + | |Polymorphous adenocarcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,897: |
Line 3,838: |
| | | | | |
| |- | | |- |
− | |Metastases to the brain and spinal cord parenchyma||Disease|| | + | |Tall cell carcinoma with reversed polarity||Disease|| |
| | | | | |
| | | | | |
Line 3,906: |
Line 3,847: |
| | | | | |
| |- | | |- |
− | |Metastases to the meninges||Disease|| | + | |Neuroendocrine tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,915: |
Line 3,856: |
| | | | | |
| |- | | |- |
− | |Neurofibromatosis type 1||Disease|| | + | |Neuroendocrine carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,924: |
Line 3,865: |
| | | | | |
| |- | | |- |
− | |Neurofibromatosis type 2||Disease|| | + | |Hamartoma||Disease|| |
| | | | | |
| | | | | |
Line 3,933: |
Line 3,874: |
| | | | | |
| |- | | |- |
− | |Schwannomatosis||Disease|| | + | |Fibroadenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,942: |
Line 3,883: |
| | | | | |
| |- | | |- |
− | |Von Hippel-Lindau syndrome||Disease|| | + | |Phyllodes tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,951: |
Line 3,892: |
| | | | | |
| |- | | |- |
− | |Tuberous sclerosis||Disease|| | + | |Syringomatous tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,960: |
Line 3,901: |
| | | | | |
| |- | | |- |
− | |Li-Fraumeni syndrome||Disease|| | + | |Nipple adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,969: |
Line 3,910: |
| | | | | |
| |- | | |- |
− | |Cowden syndrome||Disease|| | + | |Paget disease of the breast||Disease|| |
| | | | | |
| | | | | |
Line 3,978: |
Line 3,919: |
| | | | | |
| |- | | |- |
− | |Constitutional mismatch repair deficiency syndrome||Disease|| | + | |Haemangioma||Disease|| |
| | | | | |
| | | | | |
Line 3,987: |
Line 3,928: |
| | | | | |
| |- | | |- |
− | |Familial adenomatous polyposis 1||Disease|| | + | |Angiomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,996: |
Line 3,937: |
| | | | | |
| |- | | |- |
− | |Naevoid basal cell carcinoma syndrome||Disease|| | + | |Atypical vascular lesions||Disease|| |
| | | | | |
| | | | | |
Line 4,005: |
Line 3,946: |
| | | | | |
| |- | | |- |
− | |Rhabdoid tumour predisposition syndrome||Disease|| | + | |Postradiation angiosarcoma of the breast||Disease|| |
| | | | | |
| | | | | |
Line 4,014: |
Line 3,955: |
| | | | | |
| |- | | |- |
− | |Carney complex||Disease|| | + | |Primary angiosarcoma of the breast||Disease|| |
| | | | | |
| | | | | |
Line 4,023: |
Line 3,964: |
| | | | | |
| |- | | |- |
− | |DICER1 syndrome||Disease|| | + | |Nodular fasciitis||Disease|| |
| | | | | |
| | | | | |
Line 4,032: |
Line 3,973: |
| | | | | |
| |- | | |- |
− | |Familial paraganglioma syndromes||Disease|| | + | |Myofibroblastoma||Disease|| |
| | | | | |
| | | | | |
Line 4,041: |
Line 3,982: |
| | | | | |
| |- | | |- |
− | |Melanoma-astrocytoma syndrome||Disease|| | + | |Desmoid fibromatosis||Disease|| |
| | | | | |
| | | | | |
Line 4,050: |
Line 3,991: |
| | | | | |
| |- | | |- |
− | |Familial retinoblastoma||Disease|| | + | |Inflammatory myofibroblastic tumour||Disease|| |
| | | | | |
| | | | | |
Line 4,059: |
Line 4,000: |
| | | | | |
| |- | | |- |
− | |BAP1 tumour predisposition syndrome||Disease|| | + | |Schwannoma||Disease|| |
| | | | | |
| | | | | |
Line 4,068: |
Line 4,009: |
| | | | | |
| |- | | |- |
− | |Fanconi anaemia||Disease|| | + | |Neurofibroma||Disease|| |
| | | | | |
| | | | | |
Line 4,077: |
Line 4,018: |
| | | | | |
| |- | | |- |
− | |ELP1-medulloblastoma syndrome||Disease|| | + | |Granular cell tumour||Disease|| |
| | | | | |
| | | | | |
Line 4,086: |
Line 4,027: |
| | | | | |
| |- | | |- |
− | |} | + | |Leiomyoma||Disease|| |
− | | |
− | ==WHO Breast tumours (5th ed.) Content==
| |
− | {| class="wikitable"
| |
− | |-
| |
− | !'''Disease'''!!'''Page Type'''!!'''Author'''
| |
− | !'''Date Assigned to Author'''
| |
− | !'''Target Completion Date'''
| |
− | !'''Author Content (Pending or Complete)'''
| |
− | !'''Date Completed by Author'''!!'''Associate Editor'''
| |
− | !'''Date of Last Editor Review'''
| |
− | !'''Notes'''
| |
− | |- |Usual ductal hyperplasia||Disease||
| |
| | | | | |
| | | | | |
Line 4,107: |
Line 4,036: |
| | | | | |
| |- | | |- |
− | |Columnar cell lesions, including flat epithelial atypia||Disease|| | + | |Leiomyosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 4,116: |
Line 4,045: |
| | | | | |
| |- | | |- |
− | |Atypical ductal hyperplasia||Disease|| | + | |Lipoma||Disease|| |
| | | | | |
| | | | | |
Line 4,125: |
Line 4,054: |
| | | | | |
| |- | | |- |
− | |Sclerosing adenosis||Disease|| | + | |Angiolipoma||Disease|| |
| | | | | |
| | | | | |
Line 4,134: |
Line 4,063: |
| | | | | |
| |- | | |- |
− | |Apocrine adenosis and adenoma||Disease|| | + | |Liposarcoma||Disease|| |
| | | | | |
| | | | | |
Line 4,143: |
Line 4,072: |
| | | | | |
| |- | | |- |
− | |Microglandular adenosis||Disease|| | + | |Pseudoangiomatous stromal hyperplasia||Disease|| |
| | | | | |
| | | | | |
Line 4,152: |
Line 4,081: |
| | | | | |
| |- | | |- |
− | |Radial scar / complex sclerosing lesion||Disease|| | + | |Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease|| |
| | | | | |
| | | | | |
Line 4,161: |
Line 4,090: |
| | | | | |
| |- | | |- |
− | |Tubular adenoma||Disease|| | + | |Follicular lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 4,170: |
Line 4,099: |
| | | | | |
| |- | | |- |
− | |Lactating adenoma||Disease|| | + | |Diffuse large B-cell lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 4,179: |
Line 4,108: |
| | | | | |
| |- | | |- |
− | |Ductal adenoma||Disease|| | + | |Burkitt lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 4,188: |
Line 4,117: |
| | | | | |
| |- | | |- |
− | |Pleomorphic adenoma||Disease|| | + | |Breast implant-associated anaplastic large cell lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 4,197: |
Line 4,126: |
| | | | | |
| |- | | |- |
− | |Adenomyoepithelioma||Disease|| | + | |Gynaecomastia||Disease|| |
| | | | | |
| | | | | |
Line 4,206: |
Line 4,135: |
| | | | | |
| |- | | |- |
− | |Malignant adenomyoepithelioma||Disease|| | + | |Carcinoma in situ||Disease|| |
| | | | | |
| | | | | |
Line 4,215: |
Line 4,144: |
| | | | | |
| |- | | |- |
− | |Intraductal papilloma||Disease|| | + | |Invasive carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 4,224: |
Line 4,153: |
| | | | | |
| |- | | |- |
− | |Papillary ductal carcinoma in situ||Disease|| | + | |Metastases to the breast||Disease|| |
| | | | | |
| | | | | |
Line 4,233: |
Line 4,162: |
| | | | | |
| |- | | |- |
− | |Encapsulated papillary carcinoma||Disease|| | + | |BRCA1/2-associated hereditary breast and ovarian cancer syndrome||Disease|| |
| | | | | |
| | | | | |
Line 4,242: |
Line 4,171: |
| | | | | |
| |- | | |- |
− | |Solid papillary carcinoma (in situ and invasive)||Disease|| | + | |Cowden syndrome||Disease|| |
| | | | | |
| | | | | |
Line 4,251: |
Line 4,180: |
| | | | | |
| |- | | |- |
− | |Invasive papillary carcinoma||Disease|| | + | |Ataxia-telangiectasia||Disease|| |
| | | | | |
| | | | | |
Line 4,260: |
Line 4,189: |
| | | | | |
| |- | | |- |
− | |Atypical lobular hyperplasia||Disease|| | + | |Li-Fraumeni syndrome, TP53-associated||Disease|| |
| | | | | |
| | | | | |
Line 4,269: |
Line 4,198: |
| | | | | |
| |- | | |- |
− | |Lobular carcinoma in situ||Disease|| | + | |Li-Fraumeni syndrome, CHEK2-associated||Disease|| |
| | | | | |
| | | | | |
Line 4,278: |
Line 4,207: |
| | | | | |
| |- | | |- |
− | |Ductal carcinoma in situ||Disease|| | + | |CDH1-associated breast cancer||Disease|| |
| | | | | |
| | | | | |
Line 4,287: |
Line 4,216: |
| | | | | |
| |- | | |- |
− | |Invasive breast carcinoma: General overview||Disease|| | + | |PALB2-associated cancers||Disease|| |
| | | | | |
| | | | | |
Line 4,296: |
Line 4,225: |
| | | | | |
| |- | | |- |
− | |Invasive breast carcinoma of no special type||Disease|| | + | |Peutz-Jeghers syndrome||Disease|| |
| | | | | |
| | | | | |
Line 4,305: |
Line 4,234: |
| | | | | |
| |- | | |- |
− | |Microinvasive carcinoma||Disease|| | + | |Neurofibromatosis type 1||Disease|| |
| | | | | |
| | | | | |
Line 4,314: |
Line 4,243: |
| | | | | |
| |- | | |- |
− | |Invasive lobular carcinoma||Disease|| | + | |} |
− | | | + | |
− | | | + | ==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)== |
| + | {| class="wikitable sortable" |
| + | !'''Gene''' |
| + | !'''Author''' |
| + | !'''Date Assigned to Author''' |
| + | !'''Target Completion Date''' |
| + | !'''Author Content (Pending or Complete)''' |
| + | !'''Date Completed by Author''' |
| + | !'''Associate Editor''' |
| + | !'''Date of Last Editor Review''' |
| + | !'''Notes''' |
| + | |- |
| + | |BCR |
| + | |Brian Davis |
| | | | | |
| | | | | |
| + | |Complete |
| + | |8/10/18 |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |Tubular carcinoma||Disease|| | + | |ABL1 |
− | |
| + | |Brian Davis |
− | | | |
| | | | | |
| | | | | |
| + | |Complete |
| + | |4/16/19 |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |Cribriform carcinoma||Disease|| | + | |RUNX1 |
| + | |Brian Davis |
| | | | | |
| | | | | |
| + | |Complete |
| + | |6/9/19 |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |RUNX1T1 |
| + | |Brian Davis |
| | | | | |
| | | | | |
− | |- | + | |Complete |
− | |Mucinous carcinoma||Disease|| | + | |5/23/19 |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |MYH11 |
| + | |Brian Davis |
| | | | | |
| + | | |
| + | |Complete |
| + | |8/6/18 |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |Mucinous cystadenocarcinoma||Disease|| | + | |FLT3 |
− | | | + | |Kay Weng Choy |
| | | | | |
| | | | | |
| + | |Complete |
| | | | | |
| | | | | |
Line 4,359: |
Line 4,317: |
| | | | | |
| |- | | |- |
− | |Invasive micropapillary carcinoma||Disease|| | + | |NPM1 |
− | | | + | |Kay Weng Choy |
| | | | | |
| | | | | |
| + | |Complete |
| | | | | |
| | | | | |
Line 4,368: |
Line 4,327: |
| | | | | |
| |- | | |- |
− | |Carcinoma with apocrine differentiation||Disease|| | + | |TP53 |
− | | | + | |Kay Weng Choy |
| | | | | |
| | | | | |
| + | |Complete |
| | | | | |
| | | | | |
Line 4,377: |
Line 4,337: |
| | | | | |
| |- | | |- |
− | |Metaplastic carcinoma||Disease|| | + | |DNMT3A |
− | | | + | |Kay Weng Choy |
| | | | | |
| | | | | |
| + | |Complete |
| | | | | |
| | | | | |
Line 4,386: |
Line 4,347: |
| | | | | |
| |- | | |- |
− | |Acinic cell carcinoma||Disease|| | + | |CEBPA |
− | | | + | |Gordana |
| | | | | |
| | | | | |
| + | |Complete |
| | | | | |
| | | | | |
Line 4,395: |
Line 4,357: |
| | | | | |
| |- | | |- |
− | |Adenoid cystic carcinoma||Disease|| | + | |IDH1 |
− | | | + | |Paul De Fazio |
| | | | | |
| | | | | |
| + | |Complete |
| | | | | |
| | | | | |
Line 4,404: |
Line 4,367: |
| | | | | |
| |- | | |- |
− | |Secretory carcinoma||Disease|| | + | |IDH2 |
− | | | + | |Paul De Fazio |
| | | | | |
| | | | | |
| + | |Complete |
| | | | | |
| | | | | |
Line 4,413: |
Line 4,377: |
| | | | | |
| |- | | |- |
− | |Mucoepidermoid carcinoma||Disease|| | + | |PML |
− | |
| + | |Brian Davis |
− | | | |
| | | | | |
| | | | | |
| + | |Complete |
| + | |12/5/18 |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |Polymorphous adenocarcinoma||Disease|| | + | |RARA |
− | |
| + | |Brian Davis |
− | | | |
| | | | | |
| | | | | |
| + | |Complete |
| + | |8/3/18 |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |Tall cell carcinoma with reversed polarity||Disease|| | + | |ETV6 |
− | |
| + | |Brian Davis |
− | | | |
| | | | | |
| | | | | |
| + | |Complete |
| + | |6/9/19 |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |Neuroendocrine tumour||Disease|| | + | |KIT |
− | |
| + | |Brian Davis |
− | | | |
| | | | | |
| | | | | |
| + | |Complete |
| + | |10/1/18 |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |Neuroendocrine carcinoma||Disease|| | + | |CBFB |
− | |
| + | |Brian Davis |
− | | | |
| | | | | |
| | | | | |
| + | |Complete |
| + | |8/2/18 |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |Hamartoma||Disease|| | + | |GATA2 |
− | | | + | |Kay Weng Choy |
| | | | | |
| | | | | |
| + | |Complete |
| | | | | |
| | | | | |
Line 4,467: |
Line 4,437: |
| | | | | |
| |- | | |- |
− | |Fibroadenoma||Disease|| | + | |PTEN |
| + | |Beth Pitel |
| | | | | |
| | | | | |
| + | |Pending |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |MLTT3 |
| | | | | |
− | |-
| |
− | |Phyllodes tumour||Disease||
| |
| | | | | |
| | | | | |
Line 4,485: |
Line 4,457: |
| | | | | |
| |- | | |- |
− | |Syringomatous tumour||Disease|| | + | |MECOM |
− | | | + | |Brian Davis |
| | | | | |
| | | | | |
| + | |Pending |
| | | | | |
| | | | | |
Line 4,494: |
Line 4,467: |
| | | | | |
| |- | | |- |
− | |Nipple adenoma||Disease|| | + | |FGFR1(FLT2) |
| + | |Brian Davis |
| | | | | |
| | | | | |
| + | |Pending |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |KMT2A |
| | | | | |
− | |-
| |
− | |Paget disease of the breast||Disease||
| |
| | | | | |
| | | | | |
Line 4,512: |
Line 4,487: |
| | | | | |
| |- | | |- |
− | |Haemangioma||Disease|| | + | |DEK |
− | | | + | |Wahab A. Khan |
| | | | | |
| | | | | |
| + | |Pending |
| | | | | |
| | | | | |
Line 4,521: |
Line 4,497: |
| | | | | |
| |- | | |- |
− | |Angiomatosis||Disease|| | + | |NUP214 |
| + | |Wahab A. Khan |
| | | | | |
| | | | | |
| + | |Pending |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |RBM15 |
| | | | | |
− | |-
| |
− | |Atypical vascular lesions||Disease||
| |
| | | | | |
| | | | | |
Line 4,539: |
Line 4,517: |
| | | | | |
| |- | | |- |
− | |Postradiation angiosarcoma of the breast||Disease|| | + | |MKL1 |
| + | | |
| | | | | |
| | | | | |
Line 4,548: |
Line 4,527: |
| | | | | |
| |- | | |- |
− | |Primary angiosarcoma of the breast||Disease|| | + | |DDX41 |
− | | | + | |Ying Zou |
| + | |8/7/20 |
| | | | | |
| + | |Pending |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |ANKRD26 |
| | | | | |
− | |-
| |
− | |Nodular fasciitis||Disease||
| |
| | | | | |
| | | | | |
Line 4,566: |
Line 4,547: |
| | | | | |
| |- | | |- |
− | |Myofibroblastoma||Disease|| | + | |CUX1 |
| + | | |
| | | | | |
| | | | | |
Line 4,575: |
Line 4,557: |
| | | | | |
| |- | | |- |
− | |Desmoid fibromatosis||Disease|| | + | |TET2 |
| + | | |
| | | | | |
| | | | | |
Line 4,584: |
Line 4,567: |
| | | | | |
| |- | | |- |
− | |Inflammatory myofibroblastic tumour||Disease|| | + | |EZH2 |
| + | | |
| | | | | |
| | | | | |
Line 4,593: |
Line 4,577: |
| | | | | |
| |- | | |- |
− | |Schwannoma||Disease|| | + | |FOXP1 |
| + | | |
| | | | | |
| | | | | |
Line 4,602: |
Line 4,587: |
| | | | | |
| |- | | |- |
− | |Neurofibroma||Disease|| | + | |MYC |
| + | | |
| | | | | |
| | | | | |
Line 4,611: |
Line 4,597: |
| | | | | |
| |- | | |- |
− | |Granular cell tumour||Disease|| | + | |JAK2 |
| + | | |
| | | | | |
| | | | | |
Line 4,620: |
Line 4,607: |
| | | | | |
| |- | | |- |
− | |Leiomyoma||Disease|| | + | |WT1 |
| + | |DONE |
| | | | | |
| | | | | |
| + | |DONE |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |CBL |
| | | | | |
− | |-
| |
− | |Leiomyosarcoma||Disease||
| |
| | | | | |
| | | | | |
Line 4,638: |
Line 4,627: |
| | | | | |
| |- | | |- |
− | |Lipoma||Disease|| | + | |NF1 |
| + | | |
| | | | | |
| | | | | |
Line 4,647: |
Line 4,637: |
| | | | | |
| |- | | |- |
− | |Angiolipoma||Disease|| | + | |SUZ12 |
| + | | |
| | | | | |
| | | | | |
Line 4,656: |
Line 4,647: |
| | | | | |
| |- | | |- |
− | |Liposarcoma||Disease|| | + | |ERG |
| + | | |
| | | | | |
| | | | | |
Line 4,665: |
Line 4,657: |
| | | | | |
| |- | | |- |
− | |Pseudoangiomatous stromal hyperplasia||Disease|| | + | |EST2 |
| + | | |
| | | | | |
| | | | | |
Line 4,674: |
Line 4,667: |
| | | | | |
| |- | | |- |
− | |Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease|| | + | |RPS14 |
| + | | |
| | | | | |
| | | | | |
Line 4,683: |
Line 4,677: |
| | | | | |
| |- | | |- |
− | |Follicular lymphoma||Disease|| | + | |RB1 |
| + | | |
| | | | | |
| | | | | |
Line 4,692: |
Line 4,687: |
| | | | | |
| |- | | |- |
− | |Diffuse large B-cell lymphoma||Disease|| | + | |MPL |
| + | | |
| | | | | |
| | | | | |
Line 4,701: |
Line 4,697: |
| | | | | |
| |- | | |- |
− | |Burkitt lymphoma||Disease|| | + | |CHGA |
| + | | |
| | | | | |
| | | | | |
Line 4,710: |
Line 4,707: |
| | | | | |
| |- | | |- |
− | |Breast implant-associated anaplastic large cell lymphoma||Disease|| | + | |CDH1 |
| + | | |
| | | | | |
| | | | | |
Line 4,719: |
Line 4,717: |
| | | | | |
| |- | | |- |
− | |Gynaecomastia||Disease|| | + | |SRSF2 |
| + | | |
| | | | | |
| | | | | |
Line 4,728: |
Line 4,727: |
| | | | | |
| |- | | |- |
− | |Carcinoma in situ||Disease|| | + | |DNMT1 |
| + | | |
| | | | | |
| | | | | |
Line 4,737: |
Line 4,737: |
| | | | | |
| |- | | |- |
− | |Invasive carcinoma||Disease|| | + | |PRDX2 |
| + | | |
| | | | | |
| | | | | |
Line 4,746: |
Line 4,747: |
| | | | | |
| |- | | |- |
− | |Metastases to the breast||Disease|| | + | |ASXL1 |
| + | |DONE |
| | | | | |
| | | | | |
| + | |DONE |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | |MN1 |
| | | | | |
− | |-
| |
− | |BRCA1/2-associated hereditary breast and ovarian cancer syndrome||Disease||
| |
| | | | | |
| | | | | |
Line 4,764: |
Line 4,767: |
| | | | | |
| |- | | |- |
− | |Cowden syndrome||Disease|| | + | |SF3A1 |
| + | | |
| | | | | |
| | | | | |
Line 4,773: |
Line 4,777: |
| | | | | |
| |- | | |- |
− | |Ataxia-telangiectasia||Disease|| | + | |EP300 |
| + | | |
| | | | | |
| | | | | |
Line 4,782: |
Line 4,787: |
| | | | | |
| |- | | |- |
− | |Li-Fraumeni syndrome, TP53-associated||Disease|| | + | |JARID2 |
| + | | |
| | | | | |
| | | | | |
Line 4,791: |
Line 4,797: |
| | | | | |
| |- | | |- |
− | |Li-Fraumeni syndrome, CHEK2-associated||Disease|| | + | |BRCA1 |
| + | | |
| | | | | |
| | | | | |
Line 4,800: |
Line 4,807: |
| | | | | |
| |- | | |- |
− | |CDH1-associated breast cancer||Disease|| | + | |BRCA2 |
| + | | |
| | | | | |
| | | | | |
Line 4,809: |
Line 4,817: |
| | | | | |
| |- | | |- |
− | |PALB2-associated cancers||Disease||
| |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Peutz-Jeghers syndrome||Disease||
| |
| | | | | |
| | | | | |
Line 4,824: |
Line 4,826: |
| | | | | |
| | | | | |
| + | |- |
| | | | | |
| | | | | |
− | |-
| |
− | |Neurofibromatosis type 1||Disease||
| |
| | | | | |
| | | | | |
Line 4,835: |
Line 4,836: |
| | | | | |
| | | | | |
− | |-
| |
| |} | | |} |
| + | |
| + | |
| | | |
| | | |